SEC Info - Arch Therapeutics, Inc. - ‘8-K’ for 6/25/13

SEC Info℠

Home

My Interests

Help

Please Sign In

Arch Therapeutics, Inc. – ‘8-K’ for 6/25/13 – EX-21.1

On: Wednesday, 6/26/13, at 4:44pm ET · For: 6/25/13 · Accession #: 1144204-13-36721 · File #: 333-178883

Previous ‘8-K’: ‘8-K’ on 6/24/13 for 6/18/13 · Next: ‘8-K’ on / for 7/8/13 · Latest: ‘8-K’ on 4/3/24 for 3/28/24 · 15 References:

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/26/13  Arch Therapeutics, Inc.           8-K:2,3,4,5 6/25/13    9:1.4M                                   Vintage/FA

Current Report — Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML    382K 
 2: EX-10.6     Material Contract                                   HTML    188K 
 3: EX-10.7     Material Contract                                   HTML     19K 
 4: EX-10.8     Material Contract                                   HTML     53K 
 5: EX-10.9     Material Contract                                   HTML     35K 
 6: EX-16.1     Letter re: Change in Certifying Accountant          HTML      7K 
 7: EX-21.1     Subsidiaries of the Registrant                      HTML      6K 
 8: EX-99.1     Miscellaneous Exhibit                               HTML    191K 
 9: EX-99.2     Miscellaneous Exhibit                               HTML    136K

EX-21.1 — Subsidiaries of the Registrant

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EXHIBIT 21.1

SUBSIDIARIES OF ARCH THERAPEUTICS, INC.

Name		Jurisdiction
Arch Biosurgery, Inc.		Massachusetts

15 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/15/24  Arch Therapeutics, Inc.           10-K        9/30/23   68:7.9M                                   RDG Filings/FA
11/09/23  Arch Therapeutics, Inc.           S-1/A                132:17M                                    RDG Filings/FA
10/05/23  Arch Therapeutics, Inc.           S-1/A                120:16M                                    RDG Filings/FA
 1/31/23  Arch Therapeutics, Inc.           S-1/A                  7:2.3M                                   Disclosure Law Group/FA
 1/23/23  Arch Therapeutics, Inc.           S-1/A                 71:7.3M                                   Disclosure Law Group/FA
12/28/22  Arch Therapeutics, Inc.           10-K        9/30/22   67:6.8M                                   Disclosure Law Group/FA
10/26/22  Arch Therapeutics, Inc.           S-1        10/25/22  100:10M                                    Disclosure Law Group/FA
 8/26/22  Arch Therapeutics, Inc.           S-1/A                 99:8.6M                                   Disclosure Law Group/FA
 8/22/22  Arch Therapeutics, Inc.           S-1         8/19/22    4:2.3M                                   RDG Filings/FA
12/29/21  Arch Therapeutics, Inc.           10-K/A      9/30/21   12:369K                                   Toppan Merrill/FA
12/22/21  Arch Therapeutics, Inc.           POS AM               100:8.9M                                   Toppan Merrill/FA2
12/17/21  Arch Therapeutics, Inc.           10-K        9/30/21   63:6.7M                                   Toppan Merrill/FA2
 2/26/21  Arch Therapeutics, Inc.           S-1                  132:12M                                    Toppan Merrill/FA
 1/26/21  Arch Therapeutics, Inc.           POS AM                79:8.1M                                   Toppan Merrill/FA
12/11/20  Arch Therapeutics, Inc.           10-K        9/30/20   82:6.8M                                   Toppan Merrill/FA

↑Top

Filing Submission 0001144204-13-036721 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Arch Therapeutics, Inc. – ‘8-K’ for 6/25/13 – EX-21.1

On: Wednesday, 6/26/13, at 4:44pm ET · For: 6/25/13 · Accession #: 1144204-13-36721 · File #: 333-178883

Current Report — Form 8-KFiling Table of Contents

EX-21.1 — Subsidiaries of the Registrant

This exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

15 Subsequent Filings that Reference this Filing

Current Report — Form 8-K
Filing Table of Contents